Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intact Prototype Formation but Impaired Generalization in Autism.

Research in autism spectrum disorders·2012

Same author

Effects of chronic antidepressant treatment on nigrostriatal and mesolimbic dopamine autoreceptors in the rat.

Neurochemistry international·2010

Same author

Metergoline, pirenperone and pizotifen alter dopamine and 5-hydroxytryptamine synthesis in discrete rat brain nuclei.

Neurochemistry international·2010

Same author

Alterations in neuronal gene expression profiles in response to experimental demyelination and axonal transection.

Multiple sclerosis (Houndmills, Basingstoke, England)·2010

Same author

Modelling of hypoxaemia after gynaecological laparotomy.

Acta anaesthesiologica Scandinavica·2001

Same author

[Complications after spinal analgesia using three different spinal needles: Sprotee, Spinocan and Atraucan].

Ugeskrift for laeger·2000

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Chlorimipramine, fenfluramine and quipazine decrease 5-hydroxytryptamine synthesis in discrete rat brain nuclei.

¹Department of Pharmacology, Northeastern Ohio Universities, College of Medicine, Rootstown, OH 44272, U.S.A.

Neurochemistry International

|May 25, 2010

Summary

This summary is machine-generated.

A new method measures serotonin synthesis by tracking 5-hydroxytryptophan accumulation after inhibiting a key enzyme. This technique effectively indicates serotonin (5-HT) neuronal activity.

More Related Videos

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

Related Experiment Videos

Last Updated: Jun 12, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

Area of Science:

Neuroscience
Biochemistry
Pharmacology

Background:

Serotonin (5-hydroxytryptamine, 5-HT) is a crucial neurotransmitter involved in various physiological processes.
Accurate measurement of 5-HT synthesis is vital for understanding neurological function and disease.

Purpose of the Study:

To characterize a novel procedure for assessing 5-hydroxytryptamine (5-HT) synthesis.
To evaluate the utility of this method as an index of 5-HT neuronal activity.

Main Methods:

Administered m-hydroxybenzylhydrazine (an aromatic-l-amino acid decarboxylase inhibitor) and l-tryptophan to rats.
Measured the accumulation of 5-hydroxytryptophan (5-HTP) as an indicator of 5-HT synthesis.
Assessed the impact of 5-HT agonists (chlorimipramine, fenfluramine, quipazine) on 5-HTP levels.

Main Results:

5-Hydroxytryptophan (5-HTP) accumulated in a time- and dose-dependent manner after m-hydroxybenzylhydrazine and l-tryptophan administration.
5-HT agonists significantly reduced 5-HTP accumulation, indicating their influence on 5-HT synthesis.
The method showed specificity, with no significant changes observed in dopamine precursor levels (3,4-dihydroxyphenylalanine).

Conclusions:

The described procedure, measuring 5-hydroxytryptophan accumulation following enzyme inhibition and l-tryptophan loading, is a valid index of serotonin synthesis.
This method provides a reliable tool for assessing serotonin (5-HT) neuronal activity in neuropharmacological research.